A new dispute over pharmacy practice standards has opened another front in Kenya’s evolving healthcare regulation landscape, bringing into focus the delicate balance between professional qualifications, patient safety and access to essential medicines.
The debate centres on proposed Good Pharmacy Practice standards and the responsibilities assigned to different categories of pharmaceutical professionals.
The Pharmacy and Poisons Board and the Ministry of Health argue that the proposed framework is intended to strengthen professional accountability and improve patient safety.
Pharmaceutical technologists, however, fear that aspects of the proposed standards could limit their professional responsibilities, particularly in supervisory roles within health facilities.
At first glance, the dispute may appear to be a technical disagreement between professional groups. But its implications could extend to thousands of pharmacies and healthcare facilities across the country.
Pharmacists and pharmaceutical technologists form a critical part of Kenya’s healthcare delivery system. Beyond dispensing medicine, they play an increasingly important role in patient counselling, medication safety and the fight against antimicrobial resistance.
The question is therefore not simply who should occupy which position.
It is also about how Kenya can regulate a rapidly expanding pharmaceutical sector without creating unnecessary workforce gaps.
The Ministry of Health has argued that as healthcare services become increasingly specialised, the qualifications and competencies required for supervisory positions must also evolve.
This is a legitimate policy concern.
Medication errors, poor storage practices and inappropriate dispensing can have serious consequences for patients. Strong professional oversight is therefore essential.
However, regulation must also consider the realities of Kenya’s healthcare workforce.
Health facilities outside major cities often face staffing shortages. Any policy that restricts the number of professionals eligible for particular roles could create operational difficulties if alternative personnel are unavailable.
Professional associations have raised concerns about whether the proposed standards could marginalise diploma-trained pharmaceutical technologists despite their substantial presence in the healthcare system.
This highlights a broader challenge facing Kenya’s health sector: the need to align regulation with workforce realities.
Healthcare reforms work best when professional standards, training institutions and service delivery systems move in the same direction.
The introduction of new rules should therefore be accompanied by clear transition plans, adequate consultation and transparent communication.
Patients should remain at the centre of the conversation.
The ultimate purpose of professional regulation is not to create hierarchy between healthcare workers but to ensure that every Kenyan receives safe and effective pharmaceutical care.
Kenya is also confronting rising concerns around antimicrobial resistance, counterfeit medicines and self-medication. Pharmacies are increasingly becoming the first point of contact for patients seeking treatment.
That makes the quality of pharmaceutical care a major public health issue.
The ongoing debate offers an opportunity for regulators and professionals to build consensus rather than deepen divisions.
Kenya needs stronger pharmacy standards. But those standards must be practical, inclusive and designed around the realities of healthcare delivery.
The success of the reforms will ultimately be measured not by who wins the professional dispute, but by whether patients receive safer and more reliable care.
